Of the companies that reported their results last week, 18 beat analysts’ earnings forecasts, while 3 missed. On the revenue ...

The White House announced on Thursday that President Trump sent 17 major pharmaceutical companies letters delineating the ...

TORONTO -- An investigational subcutaneous autoinjector showed comparable efficacy and safety to the IV formulation of ...

Helped by higher advertising and a growing user base on its social media platforms, Meta earned $18.34 billion in the quarter ...

Little-known provisions in the Big Beautiful Bill lobbied by industry will cost Medicare billions in missed savings.

US President Donald Trump has launched a new offensive against excessive drug prices. Last week he publicly announced the sending of official letters to 17 of the world's largest pharmaceutical ...

Equities extended their July advance, with the S&P 500 set for its longest streak of monthly gains since September.

Detailed price information for Neurocrine Bioscienc (NBIX-Q) from The Globe and Mail including charting and trades.

AbbVie ( ABBV) on Thursday recorded better-than-expected financials for Q2 2025 and raised its full-year earnings outlook as the company’s newer immunology drugs offset a sharp sales decline for its ...